Correlation Between Braskem SA and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Braskem SA and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Braskem SA and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Braskem SA Class and Bionoid Pharma, you can compare the effects of market volatilities on Braskem SA and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Braskem SA with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Braskem SA and Bionoid Pharma.

Diversification Opportunities for Braskem SA and Bionoid Pharma

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Braskem and Bionoid is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Braskem SA Class and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Braskem SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Braskem SA Class are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Braskem SA i.e., Braskem SA and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Braskem SA and Bionoid Pharma

Considering the 90-day investment horizon Braskem SA Class is expected to under-perform the Bionoid Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Braskem SA Class is 9.15 times less risky than Bionoid Pharma. The stock trades about -0.37 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  25.00  in Bionoid Pharma on August 29, 2024 and sell it today you would lose (14.00) from holding Bionoid Pharma or give up 56.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Braskem SA Class  vs.  Bionoid Pharma

 Performance 
       Timeline  
Braskem SA Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Braskem SA Class has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Bionoid Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionoid Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Braskem SA and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Braskem SA and Bionoid Pharma

The main advantage of trading using opposite Braskem SA and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Braskem SA position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Braskem SA Class and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk